MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
2.170
-0.065 (-2.91%)
At close: Jul 7, 2025, 4:00 PM
2.250
+0.080 (3.69%)
After-hours: Jul 7, 2025, 6:44 PM EDT
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $230.92 million as of July 7, 2025. Its market cap has decreased by -49.91% in one year.
Market Cap
230.92M
Enterprise Value
111.48M
1-Year Change
-49.91%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $230.92M, a decrease of -53.32%. That is a compound annual growth rate of -16.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 230.92M | -47.48% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |